Share Price | Mahamaya Lifesciences Ltd Stock Analysis & Recommendation

Q: Why is Mahamaya Lifesciences Ltd falling/rising?

As of 10-Feb, Mahamaya Lifesciences Ltd's stock price is currently at Rs 189.90, reflecting a decrease of Rs 2.9, or 1.5%. This decline is evident as the stock has underperformed its sector by 1.27% today. The stock reached an intraday low of Rs 187.2, which indicates a significant drop during the trading session.Despite the current decline, it is noteworthy that Mahamaya Lifesciences Ltd has shown a positive performance over the past week, with a return of +5.62%, compared to the Sensex's +0.64%. However, over the past month, the stock has slightly decreased by 0.42%, while the Sensex has increased by 0.83%. Year-to-date, the stock has gained +2.93%, contrasting with the Sensex's decline of 1.11%.Additionally, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a generally positive trend in the longer term. There has also been a notable increase in investor participation, with delivery volume rising by 478.7% against the 5-day average, indicating heightened interest from investors.In summary, while Mahamaya Lifesciences Ltd is experiencing a decline in its stock price today, it has shown strong performance in the short term and increased investor activity, which may contribute to future price movements.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

8.4 k (66.67%) Volume

Shareholding (Nov 2025)

FII

6.39%

Held by 4 FIIs

DII

3.72%

Held by 1 DIIs

Promoter

56.35%

Which are the latest news on Mahamaya Lifesc.?

10-Feb-2026

No latest news for Mahamaya Lifesc. found.

Why is Mahamaya Lifesciences Ltd falling/rising?

11-Feb-2026

As of 10-Feb, Mahamaya Lifesciences Ltd's stock price is Rs 189.90, down 1.5% today, but it has gained 5.62% over the past week. The stock remains above key moving averages, indicating a positive long-term trend despite today's decline.

View full answer

Compare Mahamaya Lifesc. with Similar Stocks

Shivalik Rasayan Crop Life Scienc Best Agrolife

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pesticides & Agrochemicals

Market cap

INR 436 Cr (Micro Cap)

P/E

35.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

1.09

Return on Equity

25.71%

Price to Book

8.91

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

Company does not have enough history

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

Announcement Under Regulation 30 - Receiving A Prestigious Award - Company Of The Year - Medium Scale At ICSCE 2026 Dubai

22-Jan-2026 | Source : BSE

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Receiving a prestigious award - Company of the Year-Medium Scale at ICSCE 2026 Dubai

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

16-Jan-2026 | Source : BSE

Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulation 2018 please find enclosed herewith certificate received from KFIN Technologies Limited Registrar & Share Transfer Agent of the Company for the quarter ended 31st December 2025.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

16-Jan-2026 | Source : BSE

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

2.80

Debt to EBITDA (avg)

3.33

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

2.25

Tax Ratio

25.72%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

11.06%

ROCE (avg)

17.93%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

8.91

EV to EBIT

21.99

EV to EBITDA

20.40

EV to Capital Employed

4.79

EV to Sales

1.88

PEG Ratio

Dividend Yield

ROCE (Latest)

21.80%

ROE (Latest)

25.71%

Technicals key factors

Indicator

Weekly

Monthly

No records

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Nov 2025

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 4 FIIs (6.39%)

Promoter with highest holding

Krishnamurthy Ganesan (21.86%)

Highest Public shareholder

Pink Tiger Alliances Llp (10.35%)

Individual Investors Holdings

12.72%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Mahamaya Lifesc."
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "163.06",
          "val2": "146.23",
          "chgp": "11.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.58",
          "val2": "13.33",
          "chgp": "16.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.85",
          "val2": "3.55",
          "chgp": "8.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.53",
          "val2": "7.25",
          "chgp": "17.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.55%",
          "val2": "9.12%",
          "chgp": "0.43%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Mahamaya Lifesc."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 63.49% vs 17.87% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 147.89% vs 39.20% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "264.15",
          "val2": "161.57",
          "chgp": "63.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "22.94",
          "val2": "13.24",
          "chgp": "73.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.83",
          "val2": "5.90",
          "chgp": "15.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "12.94",
          "val2": "5.22",
          "chgp": "147.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.68%",
          "val2": "8.19%",
          "chgp": "0.49%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

163.06

146.23

11.51%

Operating Profit (PBDIT) excl Other Income

15.58

13.33

16.88%

Interest

3.85

3.55

8.45%

Exceptional Items

0.00

Standalone Net Profit

8.53

7.25

17.66%

Operating Profit Margin (Excl OI)

9.55%

9.12%

0.43%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

264.15

161.57

63.49%

Operating Profit (PBDIT) excl Other Income

22.94

13.24

73.26%

Interest

6.83

5.90

15.76%

Exceptional Items

0.00

Consolidate Net Profit

12.94

5.22

147.89%

Operating Profit Margin (Excl OI)

8.68%

8.19%

0.49%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 63.49% vs 17.87% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 147.89% vs 39.20% in Mar 2024

All Annual Results

Company CV

About Mahamaya Lifesciences Ltd

Mahamaya Lifesciences Ltd

Micro Cap

Pesticides & Agrochemicals

Mahamaya Lifesciences Limited was originally incorporated as a private limited Company as "Mahamaya Life Sciences Private Limited" by the Assistant Registrar of Companies, NCT Delhi & Haryana, on May 07, 2002. Further, Company's name was changed from "Mahamaya Life Sciences Private Limited" to "Mahamaya Lifesciences Private Limited" dated February 15, 2016. The status was changed to Public Limited Company on November 19, 2024 by the Central Processing Centre.

Company Coordinates

No Company Details Available